Description
RADIOPHARMACEUTICALS POP: 10/1/2020 TO 9/30/2021
First action · last action
2020-10-01 · 2022-03-25
Transactions
3
First transaction's obligation
$646,254
Base + all options value (sum of deltas)
$113,223
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
4
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2020-10-01+$646,254= $646,254
- Mod P000012022-03-03-$266,515= $379,738
- Mod P000022022-03-25-$266,515= $113,223
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2020-10-01 | +$646,254 | $646,254 | RADIOPHARMACEUTICALS POP: 10/1/2020 TO 9/30/2021 |
| Mod P00001· FUNDING ONLY ACTION | 2022-03-03 | −$266,515 | $379,738 | RADIOPHARMACEUTICALS POP: 10/1/2020 TO 9/30/2021 |
| Mod P00002· FUNDING ONLY ACTION | 2022-03-25 | −$266,515 | $113,223 | RADIOPHARMACEUTICALS POP: 10/1/2020 TO 9/30/2021 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI EQ4VSLH8RC33)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24826N0411 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $231,773 | FY2026 |
| 36C24126N0274 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $771,411 | FY2026 |
| 36C25226N0210 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $164,999 | FY2026 |
| 36C26126N0065 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $153,991 | FY2026 |
| 36C24825N0208 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $224,563 | FY2025 |
| 36C24125N0495 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $656,883 | FY2025 |
Other recipients under 6505 from 262-NETWORK CONTRACT OFFICE 22 (36C262) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26226N0873 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $140,823 | FY2026 |
| 36C26226N0871 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $231,746 | FY2026 |
| 36C26226N0870 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $167,369 | FY2026 |
| 36C26226N0872 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $164,265 | FY2026 |
| 36C26226P1412 | ASD SPECIALTY HEALTHCARE, LLC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $38,220 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26221P0012_3600_-NONE-_-NONE- · retrieved 2026-09-26.